Marshall Wace North America’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $33.2M | Sell |
359,481
-148,823
| -29% | -$13.8M | 0.14% | 161 |
|
|
2021
Q2 | $39.5M | Buy |
508,304
+92,154
| +22% | +$7.16M | 0.16% | 132 |
|
|
2021
Q1 | $31M | Buy |
416,150
+406,756
| +4,330% | +$30.3M | 0.13% | 183 |
|
|
2020
Q4 | $1.6M | Buy |
+9,394
| New | +$1.6M | 0.01% | 812 |
|
|
2020
Q3 | – | Sell |
-8,048
| Closed | -$1.29M | – | 1456 |
|
|
2020
Q2 | $1.29M | Buy |
+8,048
| New | +$1.29M | 0.01% | 695 |
|
|
2020
Q1 | – | Sell |
-56,904
| Closed | -$7.34M | – | 1576 |
|
|
2019
Q4 | $7.34M | Buy |
56,904
+54,363
| +2,139% | +$7.02M | 0.04% | 333 |
|
|
2019
Q3 | $192K | Sell |
2,541
-22,226
| -90% | -$1.68M | ﹤0.01% | 965 |
|
|
2019
Q2 | $3.76M | Sell |
24,767
-197,893
| -89% | -$30.1M | 0.02% | 421 |
|
|
2019
Q1 | $26.5M | Buy |
222,660
+50,038
| +29% | +$5.96M | 0.19% | 117 |
|
|
2018
Q4 | $18.8M | Buy |
172,622
+15,883
| +10% | +$1.73M | 0.18% | 108 |
|
|
2018
Q3 | $25.3M | Sell |
156,739
-123,102
| -44% | -$19.9M | 0.17% | 127 |
|
|
2018
Q2 | $37M | Sell |
279,841
-86,392
| -24% | -$11.4M | 0.21% | 118 |
|
|
2018
Q1 | $27.1M | Buy |
366,233
+121,512
| +50% | +$9M | 0.14% | 171 |
|
|
2017
Q4 | $13.6M | Sell |
244,721
-133,626
| -35% | -$7.43M | 0.08% | 309 |
|
|
2017
Q3 | $17M | Buy |
378,347
+365,136
| +2,764% | +$16.4M | 0.11% | 245 |
|
|
2017
Q2 | $449K | Buy |
+13,211
| New | +$449K | ﹤0.01% | 1103 |
|